Literature DB >> 30806920

Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer.

Marco Fogante1, Corrado Tagliati2, Mariagrazia De Lisa3, Rossana Berardi3, Gian Marco Giuseppetti2, Andrea Giovagnoni2.   

Abstract

PURPOSE: To evaluate a possible correlation between apparent diffusion coefficient (ADC) value and tumor-infiltrating lymphocytes (TILs) level in breast cancer (BC). A second objective was to assess whether there were other histopathologic features that could affect mean ADC value.
METHODS: In this 4-year retrospective study were included 125 patients who underwent radical or modified mastectomy for monofocal BC. All subjects had performed preoperative MRI with the same 1.5-T machine and protocol, which consisted of STIR, DWI and DCE sequences. Based on TIL score, BCs were stratified into two groups: absent-low TIL (≤ 10%) and medium-high TIL (> 10%). The t test was used to correlate mean ADC value with TIL groups. Receiver operating characteristic curve and Youden index were used in order to identify ADC value threshold to distinguish the two TIL groups.
RESULTS: BC patients with absent-low TIL level and medium-high TIL one were, respectively, 66 (52.8%) and 59 (47.2%). Mean ADC value was 1.05 ± 0.19 * 10-3 mm2 s-1. Absent-low TIL group showed a lower mean ADC value than medium-high TIL one (0.96 ± 0.18 * 10-3 mm2 s-1 vs 1.14 ± 0.16 * 10-3 mm2 s-1; p < 0.0001). ADC value threshold in order to distinguish the two TIL groups with maximum sensitivity (67.8%) and specificity (80.3%) was 1.03 * 10-3 mm2 s-1. ADC value was shown to be significantly related to TILs level (p < 0.0001) and cancer histotype (p = 0.0006), with a lower mean ADC value correlated to absent-low TIL level and ductal histotype.
CONCLUSION: BCs with absent-low TIL showed a statistically significant lower mean ADC value than those with medium-high TIL. ADC value threshold in order to distinguish these two groups was 1.03 * 10-3 mm2 s-1.

Entities:  

Keywords:  ADC; Breast cancer; MRI; TIL

Mesh:

Substances:

Year:  2019        PMID: 30806920     DOI: 10.1007/s11547-019-01008-w

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  6 in total

1.  Predicting the Level of Tumor-Infiltrating Lymphocytes in Patients With Breast Cancer: Usefulness of Mammographic Radiomics Features.

Authors:  Hongwei Yu; Xianqi Meng; Huang Chen; Jian Liu; Wenwen Gao; Lei Du; Yue Chen; Yige Wang; Xiuxiu Liu; Bing Liu; Jingfan Fan; Guolin Ma
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

Review 2.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

Review 3.  Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy.

Authors:  Jia Wu; Aaron T Mayer; Ruijiang Li
Journal:  Semin Cancer Biol       Date:  2020-12-05       Impact factor: 17.012

4.  Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker for Assessing the Level of Tumor-Infiltrating Lymphocytes: Value in Molecular Subtypes of Breast Cancer.

Authors:  Wen-Jie Tang; Zhe Jin; Yan-Ling Zhang; Yun-Shi Liang; Zi-Xuan Cheng; Lei-Xin Chen; Ying-Ying Liang; Xin-Hua Wei; Qing-Cong Kong; Yuan Guo; Xin-Qing Jiang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

Review 5.  A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response.

Authors:  Vincenza Granata; Roberta Fusco; Simona Salati; Antonella Petrillo; Elio Di Bernardo; Roberta Grassi; Raffaele Palaia; Ginevra Danti; Michelearcangelo La Porta; Matteo Cadossi; Gorana Gašljević; Gregor Sersa; Francesco Izzo
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

Review 6.  Radiomic biomarkers of tumor immune biology and immunotherapy response.

Authors:  Jarey H Wang; Kareem A Wahid; Lisanne V van Dijk; Keyvan Farahani; Reid F Thompson; Clifton David Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2021-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.